IceCure Medical Ltd (ICCM) Revenue History
Annual and quarterly revenue from 2014 to present
ICCM Revenue Over Time (2014–2025)
ICCM Revenue Growth History
8 of 11 years with positive growth- FY2014 revenue growth
- N/A
- FY2015 revenue growth
- -28.6%
- FY2016 revenue growth
- -18.0%
- FY2017 revenue growth
- +10.2%
- FY2018 revenue growth
- +55.5%
- FY2019 revenue growth
- +54.6%
- FY2020 revenue growth
- +146.4%
- FY2021 revenue growth
- +1.3%
- FY2022 revenue growth
- -25.4%
- FY2023 revenue growth
- +4.7%
- FY2024 revenue growth
- +1.9%
- FY2025 revenue growth
- +2.7%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $911K | +25.7% |
| Q4 2025 | $1.3M | +46.2% |
| Q3 2025 | $850K | +28.4% |
| Q2 2025 | $525K | -48.1% |
| Q1 2025 | $725K | -1.5% |
| Q4 2024 | $875K | -33.8% |
| Q3 2024 | $662K | +102.4% |
| Q2 2024 | $1.0M | +7.9% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown
ICCM's revenue distribution by segment and geography
By Geography
ICCM Revenue Analysis (2014–2025)
Current Revenue & Growth
As of June 4, 2026, IceCure Medical Ltd (ICCM) generated trailing twelve-month (TTM) revenue of $3.6 million, reflecting exceptional growth of +25.7% year-over-year. The most recent quarter (Q1 2026) recorded $911,000 in revenue, down 28.8% sequentially.
Historical Growth Trajectory
ICCM's 5-year compound annual growth rate (CAGR) stands at -3.7%, indicating revenue contraction over this period. The 3-year CAGR of +3.1% exceeds the 5-year average, indicating an acceleration in the most recent period. IceCure Medical Ltd's highest annual revenue of $4.1 million was recorded in 2021.
Peer Comparison
Compared to Healthcare sector peers — including NVCR (+8.5% YoY), XTNT (-0.3% YoY), and ATEC (-7.4% YoY) — ICCM has outperformed the peer group in revenue growth. Compare ICCM vs NVCR →
ICCM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 ICCMCurrent | $4M | +25.7% | -3.7% | -446.7% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 XTNT | $134M | -0.3% | +20.2% | 5.4% | |
 ATEC | $764M | -7.4% | +39.5% | -10.7% | |
 HALO | $1.4B | +39.1% | +39.2% | 58.4% | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% |
ICCM Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.4M | +2.7% | $1.2M | 36.3% | $-15,094,000 | -446.7% |
| 2024 | $3.3M | +1.9% | $1.5M | 44.1% | $-15,696,000 | -476.9% |
| 2023 | $3.2M | +4.7% | $1.3M | 40.3% | $-15,576,000 | -482.4% |
| 2022 | $3.1M | -25.4% | $1.4M | 46.8% | $-16,739,000 | -542.6% |
| 2021 | $4.1M | +1.3% | $2.2M | 53.0% | $-9,724,000 | -235.0% |
| 2020 | $4.1M | +146.4% | $2.7M | 65.1% | $-4,361,618 | -106.8% |
| 2019 | $1.7M | +54.6% | $576K | 34.8% | $-4,608,698 | -278.0% |
| 2018 | $1.1M | +55.5% | $449K | 41.9% | $-3,170,304 | -295.8% |
| 2017 | $689K | +10.2% | $175K | 25.4% | $-2,664,864 | -386.6% |
| 2016 | $625K | -18.0% | $221K | 35.4% | $-3,103,520 | -496.2% |
| 2015 | $763K | -28.6% | $277K | 36.3% | $-3,528,996 | -462.6% |
| 2014 | $1.1M | - | $376K | 35.2% | $-4,095,605 | -383.3% |
What if you invested $1,000 in ICCM back in 2014?
Total return with dividends reinvested · 12+ years of data
Calculate ReturnsHow much would $100/month in ICCM be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs ICCM Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationICCM vs DBVT — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs DBV Technologies S.A..
Compare NowICCM — Frequently Asked Questions
Quick answers to the most common questions about buying ICCM stock.
Is ICCM's revenue growth accelerating or slowing?
ICCM revenue growth is accelerating. TTM revenue reached $4M, up +25.7% year-over-year — ahead of the 5-year CAGR of -3.7%. This indicates the business is expanding faster than its historical baseline.
What is ICCM's revenue history from 2014 to 2026?
IceCure Medical Ltd (ICCM) revenue history spans 2014 to 2026. TTM revenue as of 2026 is $4M, growing at +25.7% YoY. The 5-year CAGR is -3.7%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ICCM's long-term revenue growth rate (CAGR)?
IceCure Medical Ltd's 5-year revenue CAGR of -3.7% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +25.7% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ICCM.
Why does ICCM's quarterly revenue fluctuate?
ICCM quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. IceCure Medical Ltd's revenue data from 2014 to 2026 shows full historical quarterly detail on this page.
How is ICCM's revenue distributed by segment?
ICCM reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ICCM's revenue compare to industry peers?
IceCure Medical Ltd (ICCM) with TTM revenue of $4M and +25.7% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.